Institutional members access full text with Ovid®

Share this article on:

Association between serum γ-glutamyltransferase levels and coronary microvascular function

Çiftçi, Özgüra; Güllü, Hakana; Günday, Muratb; Çalişkan, Mustafae; Kulaksizoğlu, Sevsenc; Erdoğan, Doğana; Çalişkan, Zuhald; Güven, Aytekina; Müderrisoğlu, Halduna

doi: 10.1097/MCA.0b013e32835e5c86
Pathophysiology and Natural History

Background Serum γ-glutamyltransferase (GGT) level is an independent risk factor for cardiovascular (CV) disease, and there is a strong association between serum GGT levels and most CV risk factors. However, the role of the serum GGT level as an independent risk factor for coronary microvascular function remains controversial.

Purpose We aimed to determine whether the serum GGT level is independently and specifically associated with coronary flow reserve (CFR) impairment in normal individuals.

Methods We examined healthy individuals who did not have any major CV risk factors (277), of whom CFR was achieved in 263 (95%). They were divided into three groups according to serum GGT levels. In each participant, CFR was measured using an Acuson Sequoia C256 Echocardiography System.

Results Participants with high GGT levels had significantly impaired CFR compared with those with intermediate and low GGT levels (2.82±0.49 vs. 2.71±0.51 and 2.44±0.48 U/l; P<0.0001). After adjusting for potential confounders, including sex, BMI, blood pressure, lipids, and glucose, we found that the serum GGT and high-sensitivity C-reactive protein levels were associated independently with CFR impairment (b=−0.205, P=0.007; b=−0.172, P=0.024). We also found that the serum GGT level was a good predictor of low CFR at the receiver-operating characteristic curve. The area under the curve was 75% [95% confidence interval, 0.65–0.86], and the serum GGT level was significantly predictive of a low CFR (P<0.0001).

Conclusions These results support a role for the serum GGT level as an independent marker of coronary microvascular damage and inflammation in normal individuals without concomitant risk factors.

Departments of aCardiology

bCardiovascular Surgery, Konya Application and Research Center

cBiochemistry

dGastroenterology, Baskent University Faculty of Medicine, Ankara

eDepartment of Cardiology, Medeniyet University Faculty of Medicine, Istanbul, Turkey

Correspondence to Murat Günday, MD, Department of Cardiovascular Surgery, Konya Application and Research Center, Baskent University Faculty of Medicine, Hoca Cihan Mah., Saray Cad., No: 1, 42080 Selcuklu, Konya, Turkey Tel: +90 332 2570606; fax: +90 332 2570637; e-mail: gundaymurat@yahoo.com

Received November 3, 2012

Accepted December 23, 2012

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins